Owens & Minor, Inc.

NYSE OMI

Owens & Minor, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 1.75%

Owens & Minor, Inc. Operating Income Margin is 1.75% for the Trailing 12 Months (TTM) ending September 30, 2024, a 1,792.03% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Owens & Minor, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 0.09%, a -96.86% change year over year.
  • Owens & Minor, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 2.95%, a -28.98% change year over year.
  • Owens & Minor, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 4.15%, a 180.48% change year over year.
  • Owens & Minor, Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 1.48%, a 169.87% change year over year.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
Loading...
NYSE: OMI

Owens & Minor, Inc.

CEO Mr. Edward A. Pesicka
IPO Date March 17, 1980
Location United States
Headquarters 9120 Lockwood Boulevard
Employees 20,000
Sector Health Care
Industries
Description

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.

Similar companies

HSIC

Henry Schein, Inc.

USD 71.27

0.81%

MCK

McKesson Corporation

USD 593.73

1.48%

CAH

Cardinal Health, Inc.

USD 124.03

2.62%

PDCO

Patterson Companies, Inc.

USD 30.89

0.16%

ZYXI

Zynex, Inc.

USD 7.66

-1.42%

StockViz Staff

January 15, 2025

Any question? Send us an email